论文部分内容阅读
在脑卒中病人中,脑出血占10～20％,其死亡率和致残率均高。急性期除采用常规内科治疗外,近年来微侵袭血肿抽吸术治疗脑出血疗效也得到肯定,但仍有许多病人昏迷时间长,高热和抽搐难以控制。近年来,我们采用早期静脉滴注醒脑静注射液辅助治疗,对脑出血的救治收到了明显疗效,现报告如下:1 资料与方法1.1 一般资料 所有病人均按1995年中华医学会第四次脑血管病学术会议修订标准,并经CT确诊。根据病人学龄、意识、肢体功能、出血部位、出血量配对,随机分为治疗组和对照组,两组条件基本一致(P<0.05)。
In patients with stroke, cerebral hemorrhage accounted for 10 to 20%, the mortality and morbidity were high. In addition to using conventional medical treatment in acute phase, in recent years, the efficacy of minimally invasive hematoma aspiration in the treatment of cerebral hemorrhage has also been affirmed, but there are still many patients coma for a long time, high fever and convulsions difficult to control. In recent years, we use early intravenous xingnaojing injection adjuvant therapy for the treatment of cerebral hemorrhage received significant effect, are as follows: 1 Materials and Methods 1.1 General Information All patients according to the 1995 Chinese Medical Association fourth Cerebral vascular disease meeting revised standards and confirmed by CT. Patients were divided into treatment group and control group according to their age, consciousness, limb function, bleeding site and bleeding volume. The two groups had the same conditions (P <0.05).